2019
Su J, Bylsma LC, Jiang X , Morales Arias J, Jain N, Nordyke RJ . Healthcare resource utilization among commercially insured cold agglutinin disease patients in the United States. Poster presented at the International Society for Pharmacoeconomics and Outcomes Research, New Orleans, LA, May 2019.
Publication: Abstracts and Presentations
Bylsma LC , Reichert H , Gage SM, Roy-Chaudhury P, Nordyke RJ , Fryzek J, Dahl SLM, Lithgow T, Lawson JH. 2019. Clinical outcomes of arteriovenous access in incident hemodialysis patients with Medicare coverage, 2012–2014. Am J Nephrol 49(2):156–164, doi: 10.1159/000495355 .
View Abstract
Publication: Manuscripts
2018
Jensen IS , Wu E, Sacks NC , Cyr PL , Chung KC. 2018. Budget impact analysis of using daunarubicin-cytarabine liposome in patients with newly diagnosed therapy-related AML or AML and myelodysplasia-related changes. Am Health Drug Benefits 11(7):380–386. PMID: 30647825 .
View Abstract
Publication: Manuscripts
Sacks NC . Evaluating clinical and economic burden of paroxysmal supraventricular tachycardia (PSVT) using real world evidence. Podium presentation, Real World Data and Life Science Analytics Congress. Boston, MA, October 2018.
Publication: Abstracts and Presentations
Jensen IS , Wu E, Cyr PL , Claussen M, Winkler T, Salhuddin K, Prats J, et al. Cost-consequence analysis of using cangrelor in high angiographic risk percutaneous coronary intervention (PCI) patients: A US hospital perspective. Transcatheter Cardiovascular Therapeutics (TCT), San Diego, CA, 2018.
Publication: Abstracts and Presentations
Hathway J, Purdum AG, Lin VW, Cyr PL , Westin J, Jensen IS . A budget impact model of Axicabtagene Ciloleucil in a US population of patients with relapsed/refractory large B-cell lymphoma (RR-LBCL). European Blood and Marrow Transplantation Meeting, Lisbon Portugal, 2018.
Publication: Abstracts and Presentations
Ludden T, Ermakova A, Xiong Y, Cyr PL , Sieradzan R, Sacks NC , Taylor SD. Comparison of healthcare resource utilization for multiple-daily injections (MDI) with basal and bolus insulin therapy versus non-MDI therapy in patients with Type 2 diabetes. Poster presentation at Academy of Managed Care Pharmacy Annual Research Meetings, Boston, MA, 2018.
Publication: Abstracts and Presentations
Ludden T, Ermakova A, Xiong Y, Cyr PL , Sieradzan R, Sacks NC , Taylor SD. Comparison of healthcare resource utilization and clinical status among Type 2 diabetes patients using multiple-daily injection (MDI) insulin therapy vs. non-MDI therapy. ISPOR 23rd Annual Conference, Baltimore MD, 2018.
Publication: Abstracts and Presentations
Sacks NC , Cyr PL , Bariahtaris S, Sharma A, Everson K, Douville P, Ruskin J. Healthcare resource use and expenditures in patients under 65 years of age and newly diagnosed with paroxysmal superventricular tachycardia (PSVT) in the United States. Podium Presentation at World Congress on Heart Disease, Boston MA, 2018.
Publication: Abstracts and Presentations
Hathway J, Purdum AG, Lin VW, Cyr PL , Westin J, Jensen IS . A budget impact model of axicabtagene ciloleucel (Axi-cel) in an US population of patients with relapsed or refractory large b-cell lymphoma (RR-LBCL). Podium presentation at ISPOR 23th Annual International Meeting, Baltimore MD, 2018.
A Division of